Skip to main content
TSI GROUP CO., LTD. logo

TSI GROUP CO., LTD. — Investor Relations & Filings

Ticker · 603262 ISIN · CNE1000074W9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2026-05-15 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603262

About TSI GROUP CO., LTD.

https://tsigroupltd.com/

TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.

Recent filings

Filing Released Lang Actions
技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告
Capital/Financing Update Classification · 85% confidence The document is a company announcement detailing the use of idle proceeds from prior fundraisings for cash management in the form of bank structured deposits and their redemption results. It is not a financial report, dividend notice, management change, or share transaction, but rather an update on how raised capital is being managed and the outcome of those cash management activities. This aligns with the "Capital/Financing Update" category (CAP).
2026-05-15 Chinese
技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告
Regulatory Filings Classification · 60% confidence The document is a formal announcement by a listed Chinese company regarding the use and redemption of idle fundraising proceeds in cash management products. It does not contain actual financial statements or reflect a board management change, dividends, share issues, or a full report. It is a regulatory announcement that does not fit specific categories like CAP (which covers financing activities) or IR (interim reports). Therefore, this is best classified as a general regulatory filing (RNS).
2026-05-11 Chinese
技源集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的报告
Regulatory Filings
2026-05-07 Chinese
技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告
Regulatory Filings
2026-05-07 Chinese
技源集团2025年度报告摘要
Regulatory Filings
2026-04-27 Chinese
东方证券股份有限公司关于技源集团股份有限公司2025年度日常关联交易执行情况和2026年度日常关联交易预计的核查意见
Regulatory Filings
2026-04-27 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.